MYDECINE INNOVATIONS GROUP

mydecine-innovations-group-logo

Mydecine Innovations Group is a biotechnology company that develops a novel therapeutics to treat mental health and addiction disorders. They use a world-class technology and drug development infrastructure, and advances new treatment options in areas of significant unmet need. Founded in 2020, the company is based in Vancouver, British Columbia, Canada.

#People #Financial #Event #Website #More

MYDECINE INNOVATIONS GROUP

Social Links:

Industry:
Biotechnology Life Science Therapeutics

Founded:
2013-09-27

Address:
Vancouver, British Columbia, Canada

Country:
Canada

Website Url:
http://www.mydecineinc.com

Total Employee:
11+

Status:
Active

Contact:
604-687-2038

Email Addresses:
[email protected]

Total Funding:
2.27 M USD

Technology used in webpage:
SPF Amazon Google Apps For Business GoDaddy DNS AWS Global Accelerator GoDaddy Email GoDaddy Premium DNS


Current Employees Featured

damon-michaels_image

Damon Michaels
Damon Michaels Co-Founder, Director & COO @ Mydecine Innovations Group
Co-Founder, Director & COO
2020-05-01

Stock Details


Company's stock symbol is CNSX:MYCOF

Acquisitions List

Date Company Article Price
2020-06-10 NeuroPharm NeuroPharm acquired by Mydecine Innovations Group 6 M USD

Official Site Inspections

http://www.mydecineinc.com

  • Host name: aec037177372cc6cd.awsglobalaccelerator.com
  • IP address: 15.197.225.128
  • Location: United States
  • Latitude: 37.751
  • Longitude: -97.822
  • Timezone: America/Chicago

Loading ...

More informations about "Mydecine Innovations Group" on Search Engine